Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens.

Literature DB >> 818023

Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens.

Abstract

Chelation of fresh human serum with 0.01 M MgCl2 (Mg) plus 0.01 M ethylene glycol tetraacetic acid failed to abrogate the bactericidal activity against "delayed serum-sensitive" strains of Serratia marcescens, whereas previously "promptly serum-sensitive" strains of S. marcescens and control strain Escherichia coli C were killed after an extended period of incubation. The addition of 0.01 M ethylenediametetracetate to fresh human serum neutralized bactericidal activity against S. marcescens of either serum sensitivity category.

Entities: Chemical Species

Mesh：

Substances：

Year: 1976 PMID： 818023 PMCID： PMC420762 DOI： 10.1128/iai.13.5.1343-1346.1976

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

12 in total

1. Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.

Authors: J I Gallin; R A Clark; M M Frank
Journal: Clin Immunol Immunopathol Date: 1975-01

2. Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens.

Authors: W H Traub; I Kleber
Journal: Chemotherapy Date: 1975 Impact factor: 2.544

3. Activation of the properdin pathway of complement in patients with gram-negative of bacteremia.

Authors: D T Fearon; S Ruddy; P H Schur; W R McCabe
Journal: N Engl J Med Date: 1975-05-01 Impact factor: 91.245

4. Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption.

Authors: R Snyderman; M C Pike
Journal: Infect Immun Date: 1975-02 Impact factor: 3.441

5. Activation of the classic and alternate complement pathways by endotoxin.

Authors: D P Fine
Journal: J Immunol Date: 1974-02 Impact factor: 5.422

6. C3 shunt activation in human serum chelated with EGTA.

Authors: D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal: J Immunol Date: 1972-10 Impact factor: 5.422

7. Ultrastructural surface alterations of serratia marcescens after exposure to polymyxin B and/or fresh human serum.

Authors: W H Traub; G Acker; I Kleber
Journal: Chemotherapy Date: 1976 Impact factor: 2.544

8. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.

Authors: R M Des Prez; C S Bryan; J Hawiger; D G Colley
Journal: Infect Immun Date: 1975-06 Impact factor: 3.441

5. Variable neutralization of several nonspecific antibacterial systems in fresh, defibrinated human blood by sodium polyanetholsulfonate and sodium amylosulfate.

Authors: W H Traub; P I Fukushima
Journal: J Clin Microbiol Date: 1979-07 Impact factor: 5.948

6. Inactivation of classical and alternative pathway-activated bactericidal activity of human serum by sodium polyanetholsulfonate.

Authors: W H Traub; I Kleber
Journal: J Clin Microbiol Date: 1977-03 Impact factor: 5.948

Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens.

1. Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.

2. Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens.

3. Activation of the properdin pathway of complement in patients with gram-negative of bacteremia.

4. Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption.

5. Activation of the classic and alternate complement pathways by endotoxin.

6. C3 shunt activation in human serum chelated with EGTA.

7. Ultrastructural surface alterations of serratia marcescens after exposure to polymyxin B and/or fresh human serum.

8. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.

9. Influence of the alternate complement pathway in opsonization of several bacterial species.

10. Assay of the antibiotic activity of serum.

1. Neutralization of human serum lysozyme by sodium polyanethol sulfonate but not by sodium amylosulfate.

Review 2. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

3. Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporum ovale).

4. Determination of serum bactericidal activity against Escherichia coli by an automated photometric method.

5. Variable neutralization of several nonspecific antibacterial systems in fresh, defibrinated human blood by sodium polyanetholsulfonate and sodium amylosulfate.

6. Inactivation of classical and alternative pathway-activated bactericidal activity of human serum by sodium polyanetholsulfonate.

7. Activation of complement system by porins extracted from Salmonella typhimurium.

8. Plasmid carriage and the serum sensitivity of enterobacteria.

9. Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients.

10. Studies on neutralization of human serum bactericidal activity by sodium amylosulfate.